The research report provides a big picture on Organ-on-a-chip Market Statistic key Players, on a global basis, offering a forecast and statistic in terms of revenue during the forecast period
Organ-On-a-Chip Market (OOC) is expected to hold a value of USD 1,020 Million by 2025 at a CAGR of 53%.
Market Segment Analysis
The global organ-on-a-chip market has been segmented based on organ type, application, and end-user.
The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.
Major Key Players
The key strategies followed by the players operating in the global Organ-On-a-Chip Market were innovation, product development, acquisition, and expansion.
- CN Bio Innovations Limited (UK)
- Emulate, Inc. (US)
- TissUse GmbH (Germany)
- MIMETAS BV (Netherlands)
- Hµrel Corporation
- Nortis, Inc. (US)
- InSphero (Switzerland)
- TARA Biosystems, Inc. (US)
- Axosim (US)
- Organovo Holdings Inc. (US)
- BioIVT (US)
- HemoShear Therapeutics, LLC (US)
The Organ-On-a-Chip Market In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.
The market based on application has been branched into drug discovery, toxicology research, and others. The drug discovery segment is expected to hold the largest share of the market due to the increased application of OOCs by pharmaceutical companies in drug discovery and clinical trials for the different chronic therapeutic areas. The toxicology research segment holds the second-largest share owing to increased R&D, government initiatives and funding for research institutes, and universities on OOCs in toxicology research and drug testing.
By end-user, the market has been classified as pharmaceutical companies, research organizations, and others. The pharmaceutical company’s segment is the largest segment owing to the rise in the number of pharmaceutical companies using OOCs for their R&D and drug toxicity and efficacy testing. The research organization segment is the second-largest segment owing to major universities, research organizations, non-profit research centers that are focusing on the application of OOCs in drug toxicology testing. For instance, the Wyss Institute received almost USD 5.6 million in grant money from the US FDA to use its organ-on-chip technology to test human physiological responses to radiation and to evaluate drugs designed to counter those effects in 2017.
Key Study Highlights:
- This report for Organ-On-a-Chip Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.
- The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.
Geographically, the global Organ-On-a-Chip Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa
Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/organ-on-chip-market-8498
About Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.